These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29156807)

  • 41. Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7
    Dorai T; Diouri J; O'Shea O; Doty SB
    J Cancer Ther; 2014 Apr; 5(4):369-386. PubMed ID: 24949215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Newly Released Advances in the Molecular Mechanisms of Osseous Metastasis and Potential Therapeutic Strategies.
    Rodriguez-Merchan EC; Peleteiro-Pensado M
    Arch Bone Jt Surg; 2022 Sep; 10(9):741-755. PubMed ID: 36246026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correction to 'LncRNA-Smad7 mediates cross-talk between nodal/TGF-β and BMP signaling to regulate cell fate determination of pluripotent and multipotent cells'.
    Nucleic Acids Res; 2023 Apr; 51(6):2995. PubMed ID: 36881768
    [No Abstract]   [Full Text] [Related]  

  • 44. Harnessing TGF-β and BMP signaling for expansion of p63-positive epithelial stem cells.
    Brody SL; Kaiko GE
    Stem Cell Investig; 2016; 3():82. PubMed ID: 28066784
    [No Abstract]   [Full Text] [Related]  

  • 45. Breaking Down Barriers to Chemoresistance: Role of Chemotherapy-Induced Osteoblastic Jagged1.
    Mohammad KS; Guise TA
    Cancer Cell; 2017 Dec; 32(6):717-718. PubMed ID: 29232546
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis.
    Cao L; Yang YJ; Diao JD; Zhang XH; Liu YL; Wang BY; Li ZW; Liu SX
    Oncotarget; 2017 Oct; 8(52):90308-90314. PubMed ID: 29163830
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer.
    Hilton JF; Clemons M; Pond G; Zhao H; Mazzarello S; Vandermeer L; Addison CL
    J Bone Oncol; 2018 Mar; 10():6-13. PubMed ID: 29204337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Re: Effect of Longer-interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Patients with Bone Metastases.
    Parker C
    Eur Urol; 2018 Feb; 73(2):304. PubMed ID: 29174466
    [No Abstract]   [Full Text] [Related]  

  • 49. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
    Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
    J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoblast-like cells in human cancers: new cell type and reliable markers for bone metastasis.
    Scimeca M; Bonfiglio R; Montanaro M; Bonanno E
    Future Oncol; 2018 Jan; 14(1):9-11. PubMed ID: 29219614
    [No Abstract]   [Full Text] [Related]  

  • 51. Anticarcinogenic effects of halofuginone on lung-derived cancer cells.
    Demiroglu-Zergeroglu A; Turhal G; Topal H; Ceylan H; Donbaloglu F; Karadeniz Cerit K; Odongo RR
    Cell Biol Int; 2020 Sep; 44(9):1934-1944. PubMed ID: 32437065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mechanobiological Strategies to Augment Cancer Treatment.
    Kumari A; Veena SM; Luha R; Tijore A
    ACS Omega; 2023 Nov; 8(45):42072-42085. PubMed ID: 38024751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease.
    Lee EY; Hwang J; Kim MH
    Exp Mol Med; 2023 Oct; 55(10):2116-2126. PubMed ID: 37779151
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theranostic mesoporous platinum nanoplatform delivers halofuginone to remodel extracellular matrix of breast cancer without systematic toxicity.
    Zhang J; Xu Z; Li Y; Hu Y; Tang J; Xu J; Luo Y; Wu F; Sun X; Tang Y; Wang S
    Bioeng Transl Med; 2023 Jul; 8(4):e10427. PubMed ID: 37476071
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Promising Therapeutic Approaches for Radiation-Induced Pulmonary Fibrosis: Targeting Radiation-Induced Mesenchymal Transition of Alveolar Type II Epithelial Cells.
    Wang P; Yan Z; Zhou PK; Gu Y
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological and Clinical Aspects of Metastatic Spinal Tumors.
    Litak J; Czyżewski W; Szymoniuk M; Sakwa L; Pasierb B; Litak J; Hoffman Z; Kamieniak P; Roliński J
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment.
    Sethakorn N; Heninger E; Sánchez-de-Diego C; Ding AB; Yada RC; Kerr SC; Kosoff D; Beebe DJ; Lang JM
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of TGF-β in Bone Metastases.
    Trivedi T; Pagnotti GM; Guise TA; Mohammad KS
    Biomolecules; 2021 Nov; 11(11):. PubMed ID: 34827641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Curcumin Inhibition of TGFβ signaling in bone metastatic breast cancer cells and the possible role of oxidative metabolites.
    Kunihiro AG; Brickey JA; Frye JB; Cheng JN; Luis PB; Schneider C; Funk JL
    J Nutr Biochem; 2022 Jan; 99():108842. PubMed ID: 34407450
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular matrix and its therapeutic potential for cancer treatment.
    Huang J; Zhang L; Wan D; Zhou L; Zheng S; Lin S; Qiao Y
    Signal Transduct Target Ther; 2021 Apr; 6(1):153. PubMed ID: 33888679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.